Core Insights - The expiration of the compound patent for Pyraclostrobin in China has led to a surge in domestic interest, with companies increasing registration, production, and promotion efforts [1][6] - As of 2024, there are 62 registered Pyraclostrobin products in China, including 32 active ingredients and 30 formulations, primarily targeting wheat and peanut crops [1][6] - The global market for Pyraclostrobin has seen significant growth, with sales expected to rise from $973 million in 2015 to $2.014 billion by 2024, and projected to reach $2.172 billion by 2025 [5][11] Industry Overview - Pyraclostrobin, developed by Bayer in 2004, is a broad-spectrum fungicide known for its low toxicity and effectiveness against various plant diseases [2][3] - It is particularly effective against diseases affecting cereals and legumes, making it a key product in the global fungicide market, holding an 8% market share [3][5] Market Dynamics - The Chinese market for Pyraclostrobin is expanding rapidly due to the high incidence of wheat diseases, particularly Fusarium head blight, which can cause yield losses of 10% to 20% in epidemic years [7][11] - The area affected by Fusarium head blight in China is projected to reach 15 million acres in 2024, an increase of 6 million acres from 2023 [7][8] Competitive Landscape - Major companies in the Pyraclostrobin sector include Hailir, Anhui Jiuyi, Nantong Taihe, and Guangdong Guokang, among others, with many expanding production capacity [9][10] - Hailir reported a revenue of 3.391 billion yuan in the first nine months of 2025, a 5.5% increase year-on-year, indicating strong market performance [10] Future Trends - The demand for Pyraclostrobin is expected to continue rising due to increasing occurrences of wheat diseases and advancements in application methods [11] - The market is becoming increasingly competitive, with potential oversupply leading to price fluctuations, necessitating companies to optimize production and enhance brand presence [12] - The trend towards formulation mixtures is anticipated to grow, as combining Pyraclostrobin with other chemicals can delay resistance development and enhance efficacy [13]

Investment Rating - The industry investment rating is "Outperform the Market - A" and the rating is maintained [5]. Core Insights - The new pesticide export tax rebate policy is expected to drive a "reverse involution" in the industry, potentially boosting prices and accelerating long-term transformation [1]. - The cancellation of the export tax rebate for certain pesticide products will increase export costs, leading companies to have a strong willingness to maintain prices [2]. - The policy aims to accelerate the elimination of low-quality production capacity and guide the industry towards a high-quality development direction by shifting the export structure from raw materials to formulations [3]. Summary by Sections Short-term Outlook - The upcoming spring farming season and the cancellation of the export tax rebate will provide dual support for pesticide prices, as companies may increase prices to maintain profitability [2]. Long-term Outlook - The domestic pesticide industry is experiencing high growth in investment and new projects, with an expected increase in production capacity of approximately 1.4 million tons per year from 2021 to 2024 [3]. - The policy is expected to improve capacity utilization rates, which are currently low at 66% compared to the national average for large-scale industries [3]. Industry Performance - The industry has shown strong relative performance with a 1-month return of 8.2%, a 3-month return of 10.1%, and a 12-month return of 26.1% [8].

Core Insights - Anhui Jiuyi Agricultural Co., Ltd. (referred to as "Jiuyi Co.") has filed for IPO guidance with the Anhui Securities Regulatory Bureau, with Guoyuan Securities as the advisory institution [1] - Jiuyi Co. previously submitted an IPO application to the ChiNext in June 2022 but withdrew it in October 2024 due to strategic adjustments [1] - Established in 2001, Jiuyi Co. specializes in the R&D, production, and sales of green pesticide products and is listed on the New Third Board with stock code 831006 [1] - The company ranked 54th among China's top 100 pesticide companies in 2024, with key products including efficient and environmentally friendly herbicides and fungicides [1] Industry Performance - Jiuyi Co. reported a revenue of 917 million yuan in the first half of 2025, representing a year-on-year growth of 6.02%, with a net profit of 91.93 million yuan [2] - The Chinese pesticide industry has seen growth in production, prices, and exports in 2025, but is facing increased differentiation due to policy adjustments and raw material price fluctuations [2] - The industry is moving towards high-quality and green development, necessitating compliance with new regulations and innovation in technology and product structure [2] Product Development - Jiuyi Co. has successfully overcome several foreign technical barriers in the past five years, launching multiple new products that have gained significant attention domestically and internationally [1] - The company’s product, Pymetrozine, has been widely adopted, with a cumulative application area exceeding 20 million acres, significantly improving the control of major diseases like wheat scab [1] - In 2023, Jiuyi Co.'s Pymetrozine was selected for the Ministry of Agriculture and Rural Affairs' "2024-2026 National Disaster Relief Pesticide Reserve Project" [1] - Jiuyi Co. led the formulation of the international standard for Pymetrozine in 2024 [1] Shareholding Structure - The controlling shareholder of Jiuyi Co. is Shen Yunhe, who holds a direct stake of 62.85% [3]

Core Viewpoint - Anhui Jiuyi Agricultural Co., Ltd. has announced its application for a public stock offering and listing on the Shenzhen Stock Exchange, marking a significant step in its growth strategy [1][4]. Group 1: Company Overview - Anhui Jiuyi Agricultural Co., Ltd. was established in 2001 and specializes in the research, production, and sales of green pesticide products [4]. - The company is listed on the "New Third Board" innovation layer and ranked 54th among China's top 100 pesticide companies in 2024 [4]. Group 2: Financial Performance - According to the company's mid-year report for 2025, it achieved a revenue of 916.9 million yuan, representing a year-on-year growth of 6.02% [5]. - The net profit for the same period was 91.93 million yuan [5]. Group 3: Stock Offering Details - On November 26, 2025, the company signed a stock issuance and listing guidance agreement with Guoyuan Securities Co., Ltd. [1]. - The company submitted relevant materials for the initial public offering and listing guidance to the Anhui Regulatory Bureau of the China Securities Regulatory Commission on the same day [1].

Core Viewpoint - The company, Jiangsu Suli Fine Chemical Co., Ltd., has approved the use of idle raised funds for cash management, specifically to invest up to 300 million yuan in low-risk financial products to enhance fund efficiency and returns for the company and its shareholders [2][3][15]. Group 1: Investment Management - The purpose of the entrusted financial management is to improve fund utilization efficiency while ensuring that it does not affect the investment plans of raised funds and the normal operations of the company [3]. - The amount allocated for this financial management is 100 million yuan, specifically for purchasing structured deposits from Industrial Bank Co., Ltd. [4][7]. - The source of the funds for this financial management comes from temporarily idle raised funds from the issuance of convertible bonds [5]. Group 2: Fundraising Overview - The company issued 9,572,110 convertible bonds with a total amount of 957.21 million yuan, with a net amount of 943.62 million yuan after deducting issuance costs [6]. - The funds raised are designated for various projects, including the construction of production lines for fine chemical products, with a total planned investment of 1.48 billion yuan [9]. Group 3: Financial Product Details - The financial product purchased is a structured deposit, which meets the criteria of high safety and liquidity, ensuring that it does not alter the intended use of the raised funds [10]. - The company has established a special account for the raised funds, with a tripartite supervision agreement in place to manage the funds [8]. Group 4: Risk Management - The financial products selected are low-risk investments, and the company will adhere to prudent investment principles to mitigate risks [11][12]. - The finance department will monitor the investment closely and maintain communication with relevant institutions to ensure the safety of the funds [12][13]. Group 5: Impact on the Company - The investment in low-risk short-term financial products is expected to enhance fund efficiency and yield returns without affecting the normal operation of the company's projects [15].

Core Viewpoint - The article emphasizes the development of the high-end chemical industry in Weifang, Shandong, focusing on the integration of industrial chains, digital transformation, and green development to enhance competitiveness and sustainability [2][3][5][6]. Group 1: Industrial Chain Development - Weifang is a significant chemical industry base in China, with the high-end chemical sector projected to achieve a revenue of 397 billion yuan in 2024, accounting for one-seventh of Shandong's total [3]. - The city has established a robust industrial cluster, including petrochemical, coal chemical, salt chemical, and fine chemical industries, which enhances overall competitiveness and supports regional economic growth [3][4]. - Weifang hosts seven national-level manufacturing champions, with over 30 products holding the highest global market share, showcasing its critical position in both national and global supply chains [3]. Group 2: Digital Transformation - Digital transformation is identified as a key driver for improving quality and efficiency in the chemical industry, reshaping the development landscape in Weifang [5]. - Strategic collaborations, such as the partnership between Alliance Chemical and the COSMOPlat industrial internet platform, aim to establish leading smart factories in the chemical sector [5]. - Companies like New and Achieve are exploring new paths for digital transformation, enhancing production efficiency and quality through automation and smart technologies [5]. Group 3: Green Development - The high-end chemical industry in Weifang is actively pursuing green development, integrating low-carbon practices throughout production processes [6][7]. - Companies are innovating by using renewable resources and advanced recycling technologies to minimize carbon footprints and energy consumption [6][7]. - The successful implementation of green technologies demonstrates that the industry's economic and environmental goals can be mutually reinforcing, contributing to a sustainable future [7].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 20.90 CNY based on a projected EPS of 0.95, 1.35, and 1.79 CNY for 2025-2027 [4][7]. Core Views - The company experienced a year-on-year revenue growth of 6.84% in Q2, driven by a 9.20% increase in pesticide sales, despite a 1.26% decline in average product prices [10]. - The company's gross profit margin for Q2 was 23.79%, remaining stable year-on-year, while net profit increased by 35.24% to 0.97 billion CNY due to reduced asset impairment losses [10]. - The Hengning base is expected to continue reducing losses as its operational efficiency improves, potentially contributing positively in the future [10]. Financial Summary - Revenue for 2023 is projected at 4,398 million CNY, with a decline of 3.0% year-on-year, followed by a forecasted increase of 23.6% in 2025 [6]. - Operating profit is expected to drop to 242 million CNY in 2024, a decrease of 57.5%, before recovering to 378 million CNY in 2025 [6]. - The net profit attributable to the parent company is forecasted to be 473 million CNY in 2023, with a significant drop of 61.7% in 2024, followed by a recovery to 324 million CNY in 2025 [6]. - The company’s gross margin is expected to decline to 23.9% in 2024, before gradually improving to 25.7% by 2027 [6].

Core Viewpoint - The company's second-quarter performance showed a year-on-year increase driven by sales growth and a reduction in impairment losses, despite a generally low industry sentiment and price pressures on key products [1][2]. Group 1: Sales and Financial Performance - The company's pesticide business saw a 9.20% year-on-year increase in sales volume in the second quarter, leading to a revenue of 1.345 billion, which is a 6.84% increase year-on-year [1]. - The average price of the company's pesticide products decreased by 1.26% year-on-year in the second quarter, indicating stabilization after a period of decline [1]. - The net profit attributable to the parent company reached 97 million in the second quarter, reflecting a year-on-year growth of 35.24%, primarily due to reduced asset impairment losses [1]. Group 2: Operational Developments - The Hengning subsidiary, a key growth driver for the company, has seen an increase in operational efficiency, with total assets reaching nearly 2 billion [1]. - The Hengning project has faced challenges since its initial production in June 2022, resulting in losses of 141 million and 163 million for 2023 and 2024, respectively, attributed to high initial investment and low utilization rates [2]. - Improvements in the Hengning project are expected as production capacity utilization increases, leading to a reduction in losses and potential positive contributions in the future [2]. Group 3: Profit Forecast and Investment Recommendations - Due to the declining prices of key products in the pesticide industry, the company's earnings per share (EPS) forecasts for 2025-2027 have been adjusted to 0.95, 1.35, and 1.79, down from previous estimates [3]. - The target price is set at 20.90, based on a 22 times price-to-earnings ratio for comparable companies, while maintaining a buy rating [3].

Group 1 - The company has released its 2025 semi-annual report, ensuring the accuracy and completeness of the information provided [1][3][48] - The company will hold its second extraordinary general meeting of shareholders on September 19, 2025, to discuss various proposals [6][43] - The board of directors has approved the cancellation of the supervisory board and the revision of the company's articles of association [88][89] Group 2 - The company reported a total of 9,572,110 convertible bonds issued, raising a total of RMB 957.21 million, with a net amount of RMB 943.62 million after deducting issuance costs [58] - As of June 30, 2025, the company has utilized RMB 779.63 million of the raised funds, with a remaining balance of RMB 57.46 million [59][60] - The company has established special accounts for the management of raised funds, ensuring compliance with relevant regulations [61][62] Group 3 - The company has proposed to revise several internal governance systems to enhance operational standards and protect shareholder rights [86] - The company plans to change the construction content of its fundraising projects to better align with market demand and strategic planning [81][82] - The company has not used idle raised funds to temporarily supplement working capital or for other unauthorized purposes [71][75]

Summary of Key Points Core Viewpoint The announcement provides a detailed account of Jiangsu Suli Fine Chemical Co., Ltd.'s fundraising activities, including the amount raised, its usage, and the management of the funds, ensuring compliance with regulatory requirements. Fundraising Overview - The company raised a total of RMB 957.21 million through the issuance of convertible bonds, with a net amount of RMB 943.62 million after deducting issuance costs [1]. - The funds were deposited into a dedicated account approved by the board of directors and have been verified by an accounting firm [1]. Previous Year Fund Usage - As of December 31, 2024, the cumulative investment from the raised funds amounted to RMB 671.38 million, with RMB 131.69 million initially invested from the company's own funds [2]. - By June 30, 2025, the total investment from the raised funds reached RMB 779.63 million, with RMB 108.25 million used in the current year [2]. Fund Management and Storage - The company has established a management system for the raised funds in accordance with relevant laws and regulations to protect investor interests [4]. - Multiple dedicated accounts have been opened at various banks for the management of the raised funds, ensuring that the funds are used strictly for their intended purposes [5]. Cash Management of Idle Funds - The company has approved the use of idle raised funds for cash management, allowing for investment in low-risk financial products to enhance returns while ensuring that the investment plans are not affected [8]. - The company has received returns from cash management activities, with specific amounts detailed for each fiscal year [8]. Changes in Fund Usage - The company has proposed changes to the investment projects funded by the raised capital, increasing the production capacity of certain chemical products [9]. - The total planned investment for the revised projects is RMB 148.33 million, with the amount from raised funds remaining at RMB 94.36 million [9]. Compliance and Reporting - The company has adhered to regulatory requirements for the management and usage of raised funds, with no violations reported [9]. - Detailed reports on the usage of funds have been disclosed, ensuring transparency and accountability [9].